Back to Search
Start Over
The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection.
- Source :
-
Leukemia [Leukemia] 2020 Oct; Vol. 34 (10), pp. 2790-2793. Date of Electronic Publication: 2020 Jul 06. - Publication Year :
- 2020
- Subjects :
- Animals
Disease Models, Animal
Female
Hepatitis B diagnosis
Hepatitis B immunology
Humans
Male
Mice
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma immunology
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen
T-Lymphocytes immunology
T-Lymphocytes metabolism
Treatment Outcome
Xenograft Model Antitumor Assays
Hepatitis B complications
Hepatitis B virology
Hepatitis B virus immunology
Immunotherapy, Adoptive adverse effects
Immunotherapy, Adoptive methods
Precursor Cell Lymphoblastic Leukemia-Lymphoma complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 34
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Academic Journal
- Accession number :
- 32632097
- Full Text :
- https://doi.org/10.1038/s41375-020-0952-4